Meritage Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,180
| Closed | -$322K | – | 24 |
|
|
2024
Q2 | $322K | Buy |
1,180
+424
| +56% | +$116K | 0.01% | 28 |
|
|
2024
Q1 | $261K | Sell |
756
-61
| -7% | -$21.1K | 0.01% | 47 |
|
|
2023
Q4 | $264K | Buy |
+817
| New | +$264K | 0.01% | 41 |
|
|
2023
Q3 | – | Sell |
-753
| Closed | -$285K | – | 53 |
|
|
2023
Q2 | $285K | Buy |
+753
| New | +$285K | 0.01% | 27 |
|
|
2022
Q3 | – | Sell |
-469
| Closed | -$232K | – | 38 |
|
|
2022
Q2 | $232K | Sell |
469
-324
| -41% | -$160K | 0.01% | 28 |
|
|
2022
Q1 | $447K | Sell |
793
-229
| -22% | -$129K | 0.01% | 18 |
|
|
2021
Q4 | $772K | Buy |
1,022
+566
| +124% | +$428K | 0.01% | 17 |
|
|
2021
Q3 | $340K | Sell |
456
-415
| -48% | -$309K | 0.01% | 25 |
|
|
2021
Q2 | $561K | Buy |
871
+142
| +19% | +$91.5K | 0.01% | 17 |
|
|
2021
Q1 | $416K | Buy |
729
+57
| +8% | +$32.5K | 0.01% | 21 |
|
|
2020
Q4 | $392K | Sell |
672
-89
| -12% | -$51.9K | 0.01% | 25 |
|
|
2020
Q3 | $392K | Buy |
+761
| New | +$392K | 0.01% | 22 |
|